Overview

ACTH Treatment of APOL1- Associated Nephropathy

Status:
Withdrawn

Trial end date:
2019-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to determine if the study drug H.C. Acthar gel slows the progression of your kidney disease. This drug is a steroid-based medicine with fewer side effects than other steroids used for treatment of kidney diseases similar to APOL1 nephropathy.

Phase:

N/A

Details

Lead Sponsor:

Wake Forest University Health Sciences

Treatments:

Adrenocorticotropic Hormone